Current Therapy of the Patients with MDS: Walking towards Personalized Therapy

Current Therapy of the Patients with MDS: Walking towards Personalized Therapy

Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis, dysplasia and peripheral cytopenias. Nowadays, MDS therapy is selected based on risk. The goals of therapy are different in low-risk and high-risk patients. In low-risk MDS, the goal is to decrease transfusion needs and...

Full description

Bibliographic Details
Main Authors: Maria Luisa Palacios-Berraquero, Ana Alfonso-Piérola
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
myelodysplastic syndrome
treatment
luspatercept
azacitidine
pevonedistat
magrolimab
Online Access:https://www.mdpi.com/2077-0383/10/10/2107

Similar Items

Similar Items